Workflow
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
BRTXBioRestorative Therapies(BRTX) ZACKS·2024-06-11 22:50

This quarterly report represents an earnings surprise of -3.92%. A quarter ago, it was expected that this company would post a loss of 0.65persharewhenitactuallyproducedalossof0.65 per share when it actually produced a loss of 0.57, delivering a surprise of 12.31%. Biorestorative Therapies, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of 0.04millionforthequarterendedMarch2024,surpassingtheZacksConsensusEstimateby16.670.04 million for the quarter ended March 2024, surpassing the Zacks Consensus Estimate by 16.67%. This compares to year-ago revenues of 0.03 million. The company has t ...